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In oval-shaped Streptococcus pneumoniae, septal and longitudinal
peptidoglycan syntheses are performed by independent functional
complexes: the divisome and the elongasome. Penicillin-binding pro-
teins (PBPs) were long considered the key peptidoglycan-synthesizing
enzymes in these complexes. Among these were the bifunctional
class A PBPs, which are both glycosyltransferases and transpepti-
dases, and monofunctional class B PBPs with only transpeptidase ac-
tivity. Recently, however, it was established that the monofunctional
class B PBPs work together with transmembrane glycosyltransferases
(FtsW and RodA) from the shape, elongation, division, and sporula-
tion (SEDS) family to make up the core peptidoglycan-synthesizing
machineries within the pneumococcal divisome (FtsW/PBP2x) and
elongasome (RodA/PBP2b). The function of class A PBPs is therefore
now an open question. Here we utilize the peptidoglycan hydrolase
CbpD that targets the septum of S. pneumoniae cells to show that
class A PBPs have an autonomous role during pneumococcal cell wall
synthesis. Using assays to specifically inhibit the function of PBP2x
and FtsW, we demonstrate that CbpD attacks nascent peptidoglycan
synthesized by the divisome. Notably, class A PBPs could process this
nascent peptidoglycan from a CbpD-sensitive to a CbpD-resistant form.
The class A PBP-mediated processing was independent of divisome
and elongasome activities. Class A PBPs thus constitute an autono-
mous functional entity which processes recently formed peptidoglycan
synthesized by FtsW/PBP2×. Our results support a model in which
mature pneumococcal peptidoglycan is synthesized by three functional
entities, the divisome, the elongasome, and bifunctional PBPs. The
latter modify existing peptidoglycan but are probably not involved
in primary peptidoglycan synthesis.
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The peptidoglycan layer covering the pneumococcal cell pro-vides shape and rigidity and is essential for growth and sur-
vival. It consists of linear chains of two alternating amino sugars,
N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid
(MurNAc), interlinked by peptide bridges between MurNAcs on ad-
jacent strands (1, 2). Peptidoglycan is synthesized from lipid II precur-
sors on the outside of the cytoplasmic membrane by glycosyltransferases
that polymerize the glycan chains and transpeptidases that in-
terconnect the chains through peptide cross-links. Streptococcus
pneumoniae produces five different penicillin-binding proteins
(PBPs) with transpeptidase activity, namely, PBP1a, PBP1b,
PBP2a, PBP2b, and PBP2x (3). The first three of these, designated
class A PBPs, are bifunctional enzymes that catalyze transglycosylation
as well as transpeptidation, while PBP2x and PBP2b are monofunc-
tional transpeptidases (class B PBPs) (4). Monofunctional glycosyl-
transferases that have homology to the glycosyltransferase domains of
class A PBPs are present in some bacterial species but are absent from
S. pneumoniae. PBP2x is an essential constituent of the divisome, a
multiprotein division machine that synthesizes the septal cross wall (3,
5–7). The other monofunctional transpeptidase, PBP2b, is a key
component of another multiprotein complex, the elongasome,
which is responsible for longitudinal peptidoglycan synthesis (3, 5–
8). Until recently, it was believed that only class A PBPs were able
to polymerize glycan chains in S. pneumoniae. Consequently, the
divisome as well as the elongasome would have to include at least
one class A PBP in order to be functional. Recently, however, it
was discovered that FtsW and RodA, two proteins belonging to
the SEDS (shape, elongation, division, and sporulation) family,
function as peptidoglycan polymerases that synthesize glycan
strands from lipid II (9–11). FtsW and RodA were originally
reported to be lipid II flippases, a function now assigned to MurJ
(12). However, it is still not entirely clear whether these polytopic
membrane proteins are monofunctional glycan polymerases or
bifunctional flippases and polymerases (13, 14). Previous research
has shown that FtsW and RodA are essential and work in con-
junction with PBP2x and PBP2b, respectively (9, 11).
Peptidoglycan synthesis requires the concerted action of enzymes
that carry out transglycosylation and transpeptidation reactions. Thus,
in principle, peptidoglycan synthesis might be performed by mono-
functional transglycosylases working together with monofunctional
transpeptidases, by single bifunctional enzymes such as the class A
PBPs, or by a combination of monofunctional and bifunctional en-
zymes. As mentioned above, class A PBPs have traditionally been
considered to be essential components of bacterial divisomes and
elongasomes. However, it has been known for a long time that Ba-
cillus subtilis is viable without class A PBPs (15). Thus, considering the
recent discovery of the SEDS partners of PBP2x and PBP2b, it is
conceivable that the pneumococcal divisome and elongasome per-
form the primary synthesis of septal and peripheral peptidoglycan
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without the involvement of class A PBPs. If so, the function of class A
PBPs is an open question, and their role in peptidoglycan synthe-
sis must be reexamined. Here we have addressed this question by
exploiting the unique properties of the peptidoglycan hydrolase
CbpD (choline-binding protein D).
CbpD is composed of three domains: an N-terminal cysteine,
histidine-dependent amidohydrolase/peptidase (CHAP) domain,
one or two Src homology 3b (SH3b) domains, and a C-terminal
choline-binding domain (Cbd) consisting of four choline-binding
repeats (16). CHAP domains are present in many peptidoglycan
hydrolases and function as either N-acetylmuramoyl-L-alanine
amidases or endopeptidases (17, 18). Hence, the CHAP domain
of CbpD cleaves somewhere within the peptide bridges of
streptococcal peptidoglycan. However, the exact bond cleaved
has not been identified. The SH3b domain is essential for the
function of CbpD, and experimental evidence indicates that it
binds to the peptidoglycan portion of the cell wall (16). The
choline-binding repeats of the Cbd domain anchor CbpD to cell
wall teichoic acid and possibly also lipoteichoic acid through
noncovalent interactions with the choline residues decorating
these polymers (19). Similar to the CHAP and SH3b domains,
the Cbd domain is essential for the biological function of
CbpD (16).
Even though CbpD appears to be a key component of the
pneumococcal gene transfer machinery, it is still poorly charac-
terized. In the present study, we were able to purify the CbpD
protein from Streptococcus mitis B6 (CbpD-B6) and show that it
specifically cleaves nascent peptidoglycan formed by the pneu-
mococcal PBP2x/FtsW machinery. We utilized this unique
specificity of CbpD to study the functional relationships between
different peptidoglycan-synthesizing enzymes in S. pneumoniae.
Our results strongly indicate that class A PBPs are not part of the
core machineries of the divisome and elongasome but have an
important autonomous role in the construction of the fully ma-
tured peptidoglycan layer.
Results
CbpD-B6 Attacks the Septal Area of the Pneumococcal Cell Wall. It
has previously proved very difficult to express and purify the
pneumococcal peptidoglycan hydrolase CbpD from S. pneumoniae
strain R6 (CbpD-R6). In order to further study the properties of
this enzyme, we therefore searched for homologous CbpD vari-
ants in other streptococcal species. The CbpD allele from S. mitis
B6 (CbpD-B6) is highly homologous to CbpD-R6. Their CHAP
and Cbd domains are 96% and 95% identical, respectively. The
major difference between them is that CbpD-R6 contains an extra
SH3b domain (SI Appendix, Fig. S1). We were able to successfully
purify CbpD-B6 using diethylaminoethyl (DEAE) cellulose af-
finity chromatography (20) and size exclusion chromatography (SI
Appendix, Fig. S2). The R6 strain is highly sensitive to CbpD-B6,
and a concentration of 0.3 μg mL−1 lyses 50% of the cells in an R6
culture at an optical density at 550 nm (OD550) of 0.2 (see the
titration experiment in SI Appendix, Fig. S3). To rule out the
possibility that lysins from the Escherichia coli expression host
contaminated the CbpD-B6 protein preparation, a control ex-
periment was performed in which choline (2% final concentra-
tion) was added together with the CbpD-B6 preparation to the
pneumococcal culture. Exogenously added choline binds to the
Cbd domain of CbpD-B6 and inhibits its function by blocking its
binding to the choline residues decorating pneumococcal teichoic
acids (20). No lysis was observed in the presence of 2% choline (SI
Appendix, Fig. S4). As no choline-binding lysins are produced by
E. coli, this shows that the observed muralytic activity is caused by
CbpD-B6. The purified CbpD-B6 protein preparation was there-
fore used for further studies.
Pneumococci exposed to purified recombinant CbpD-B6 were
examined by scanning electron microscopy (SEM) for visualiza-
tion of changes in their ultrastructure. The SEM microscopy
analysis clearly showed that CbpD-B6 attacks only the septal
region of the peptidoglycan sacculus, resulting in cells that are
split in half along their equators (Fig. 1). Interestingly, the rims
of both hemispheres in the split cells are thicker than the rest of
the peptidoglycan layer. This suggests that CbpD-B6 cleaves the
cells along the middle of the equatorial ring, also called the
piecrust.
CbpD-B6 Specifically Cleaves Nascent Peptidoglycan Formed by PBP2x
and FtsW. Since CbpD-B6 attacks the septal region of the cell, we
speculated that the enzyme targets the peptidoglycan formed by
PBP2x and FtsW. If so, specific inhibition of the divisome activity
might render pneumococci less sensitive or insensitive to CbpD-B6.
In a recent profiling of the β-lactam selectivity of pneumococcal
PBPs, Kocaoglu et al. (21) showed that PBP2x is more sensitive
than PBP1a, PBP1b, PBP2a, and PBP2b to several different
β-lactams. Hence, by using the appropriate β-lactam at the right
concentration it should be possible to inhibit the transpeptidase
activity of PBP2x without significantly affecting the function of the
other PBPs. To test this hypothesis, we grew pneumococcal cul-
tures in 96-well plates in a microplate reader at 37 °C. When
reaching OD550 ∼ 0.2, each culture was treated with a different
concentration of oxacillin. The oxacillin concentrations used
ranged from 0 to 100 μg mL−1, i.e., from sub- to supra-minimum
inhibitory concentrations (MICs). Ten minutes after being exposed
to oxacillin, each culture received 5 μg mL−1 of purified CbpD-B6.
Comparison of the lytic responses of the cultures showed that the
extent of lysis gradually decreased with increasing oxacillin con-
centrations until the cells became resistant to CbpD-B6 at con-
centrations between 0.19 and 6.1 μg mL−1 (Fig. 2A). The lowest
antibiotic concentration that gave full protection against CbpD-B6
(0.19 μg mL−1) corresponds roughly to the MIC value of oxacillin
against the R6 strain (SI Appendix, Fig. S5A). However, to our
great surprise, the pneumococci started to lyse again when the
concentration of oxacillin was increased further, i.e., above
6.1 μg mL−1. At the highest oxacillin concentrations used (50
and 100 μg mL−1), the pneumococci became as sensitive as
untreated control cells (Fig. 2A). In sum, the results show that
as the oxacillin concentration is gradually increased, the lytic
response to CbpD-B6 shifts from decreasing sensitivity (S1 phase)
to resistance (R phase) and then back to increasing sensitivity
(S2 phase).
In line with the observations above (Fig. 1), GFP-CbpD has
previously been shown to mainly bind the septal region of
pneumococcal cells, and the binding specificity is determined by
the C-terminal choline-binding domain (16). To test whether
CbpD resistance during the R phase could be explained by al-
tered binding of CbpD after exposure to oxacillin, we analyzed
the binding patterns of sfGFP-CbpD-B6 as previously described
(16). The fusion protein was expressed and purified essentially as
CbpD-B6 and exposed to RH425 control cells as well as RH425
cells treated with 0.8 μg mL−1 oxacillin for 10 min (resulting in R
phase cells, Fig. 2A). sfGFP-CbpD-B6 retained the localization
to the septal region after oxacillin treatment for cells in all di-
vision stages (Fig. 3A), although the fraction of cells without
septal sfGFP-CbpD-B6 was slightly higher than in the control
cells (6.7% in control cells and 11.8% after oxacillin treatment,
Fig. 3B). This shows that the R phase cannot be explained by
alterations in the binding pattern of sfGFP-CbpD-B6.
Βeta-lactam-resistant pneumococci have acquired so-called
low-affinity PBPs, modified PBPs that have much lower affinity
for β-lactams than the corresponding PBPs of sensitive strains.
To verify that the R phase is due to inhibition of PBP2x by ox-
acillin, the experiment described above was repeated with an R6
mutant strain (KHB321) expressing a low-affinity version of
PBP2x (SI Appendix, Fig. S5B). The KHB321 mutant was con-
structed by replacing the extracytoplasmic part of R6-pbp2x with
the corresponding part of the low-affinity pbp2x gene from





















































S. mitis strain B6 (SI Appendix, Fig. S6). The B6 strain is a highly
penicillin resistant clinical isolate that produces low-affinity
versions of PBP2x, PBP2b, and PBP1a (22). When the oxacillin
titration experiment was carried out with the KHB321 strain, no
R phase was obtained within the concentration range used (0 to
100 μg mL−1 oxacillin) (Fig. 2B). This result clearly shows that
inhibition of the transpeptidase activity of PBP2x by oxacillin
causes the R phase.
Fig. 1. CbpD-B6 specifically attacks the septal region. Scanning electron micrographs of untreated pneumococci (A) and pneumococci subjected to 0.5 μg mL−1
CbpD-B6 for 60 s before they were fixed and prepared for electron microscopy (B–D). Arrows indicate areas in the cell wall attacked by the muralytic enzyme.
Fig. 2. Inhibition of the core peptidoglycan-synthesizing machinery of the divisome (PBP2x/FtsW) produces CbpD-B6-resistant peptidoglycan. (A) Increasing
concentrations of oxacillin were added to exponentially growing wild-type (WT) cells (RH425) at OD550 ∼ 0.25 (black arrow). After 10 min, CbpD-B6 was added
(red arrow) to a final concentration of 5 μg mL−1. The cells were susceptible to CbpD-B6 at concentrations ranging from 0 to 0.09 μg mL−1 oxacillin (S1 phase,
red curves), resistant from 0.19 to 6.125 μg mL−1 (R phase, green curves), and susceptible from 12.5 to 100 μg mL−1 (S2 phase, blue curves). (B) Pneumococci
expressing a PBP2x homolog (LA-PBP2x, strain KHB321) with low affinity for β-lactam antibiotics did not give rise to CbpD resistance when subjected to
increasing concentrations of oxacillin. (C and D) Strong depletion (green curves) of FtsW (strain css12) and PBP2x (strain SPH163) results in cells resistant to
CbpD-B6 (red arrows indicate addition of 5 μg mL−1 of CbpD-B6).





























































Moreover, the results above show that CbpD-B6 specifically
attacks the peptidoglycan formed by PBP2x/FtsW in the divisome.
To further substantiate this conclusion, we investigated whether
loss of FtsW activity would give rise to resistance against CbpD-B6.
Since FtsW is essential and no specific inhibitor is known, we
decided to deplete the expression of this peptidoglycan polymerase
using the ComRS system (see Western blot in SI Appendix, Fig.
S7) as described before (8, 23). Supporting our conclusion, the
results showed that strongly depleted cells became fully resistant to
CbpD-B6 (Fig. 2C). As expected, depletion of PBP2x gave the
same result (Fig. 2D). The morphology of pneumococcal cells
strongly depleted of PBP2x (8) or FtsW (SI Appendix, Fig. S7) is
the same; both become elongated and somewhat enlarged.
The S2 Phase Results from Inhibition of the PBPs Processing PBP2x/
FtsW-Synthesized Peptidoglycan. During the S1 phase the oxacillin
concentration increases gradually, resulting in progressively
stronger inhibition of PBP2x. This causes a gradual reduction in
the number of nascent peptide bridges formed by PBP2x and,
eventually, complete inhibition of its transpeptidase activity in
the R phase. While this line of reasoning provides an explanation
for the S1 and R phases, it does not explain the S2 phase. How
can a further increase in oxacillin concentration lead to increased
cell lysis when PBP2x is completely inhibited? We observed that
the R phase disappears if oxacillin (0.8 μg mL−1) and CbpD-B6
are added simultaneously to pneumococcal cultures. After being
exposed to oxacillin it takes about 3.5 min before 95% of the
cells develop full resistance against CbpD-B6 (Fig. 4). This shows
that the peptidoglycan initially formed by the PBP2x/FtsW ma-
chinery must undergo some kind of processing before it becomes
resistant to CbpD-B6, an operation that takes several minutes.
This finding suggested a plausible explanation for the S2 phase.
Although PBP2x is more sensitive than the other pneumococcal
PBPs to oxacillin, a further increase in oxacillin concentration
will eventually affect the transpeptidase activity of the less sen-
sitive PBPs. Presumably, the activity of one or more of these
PBPs is required to modify PBP2x/FtsW-synthesized peptido-
glycan into a CbpD-B6-resistant form. Consequently, the cells
will not become resistant if their activity is blocked. The reason
for this is that newly synthesized CbpD-B6-sensitive peptidogly-
can will still be present if the activities of PBP2x and the PBP(s)
required for processing this peptidoglycan are blocked simulta-
neously. In sum, our results indicate that the S2 phase results
from inhibition of the PBP(s) required for processing PBP2x/
FtsW-synthesized peptidoglycan into a CbpD-B6-resistant form.
Peptidoglycan Synthesized by the FtsW/PBP2x Machinery Is Further
Processed by Class A PBPs. To determine whether class A PBPs are
required to produce CbpD-B6-resistant peptidoglycan, the oxacillin
titration experiment described above was performed in the presence
of 10 μg mL−1 of the antibiotic moenomycin. Moenomycin inhibits
bacterial growth by blocking the transglycosylase activity of class A
Fig. 3. Binding of sfGFP-CbpD-B6 to oxacillin-treated S. pneumoniae RH425
cells. (A) Binding of sfGFP-CbpD-B6 to fixed S. pneumoniae cells in five stages
of division. Phase contrast (PC) and GFP images of nontreated control cells (0
μg mL−1 oxacillin, S1 phase cells) and cells treated with 0.8 μg mL−1 oxacillin
for 10 min (R phase cells) are included. (B) Proportion of cells with sfGFP-
CbpD-B6 enriched in the septal region for both groups of cells. The num-
bers of oxacillin-treated and nontreated cells analyzed were 170 and 180,
respectively. The scale bar is 1 μm.
Fig. 4. Kinetics of CbpD resistance development in pneumococcal cells
where PBP2x/FtsW-mediated peptidoglycan synthesis has been blocked by
the addition of 0.8 μg mL−1 oxacillin. Oxacillin was added simultaneously to
11 parallel cultures of wild-type cells at OD550 ∼ 0.25. To check for sensitivity
to CbpD-B6, 1 μg mL−1 of the hydrolase was added to a different culture
every minute for 0 to 10 min. The results are presented as percent reduction
in OD550 caused by cell lysis. After about 3.5 min 95% of the cells were re-
sistant to CbpD-B6 (dashed line), demonstrating that pneumococcal cells
need time to transform newly synthesized septal peptidoglycan into a CbpD-
B6-resistant form. Mean estimates (n = 3) together with their SDs are shown.
The curve was fitted using a sixth-order polynomial equation (see Materials
and Methods).





















































PBPs but does not affect FtsW and RodA (9). Our results showed
that in the presence of moenomycin the S1–R–S2 pattern dis-
appeared, and the pneumococci were sensitive to CbpD-B6 at all
oxacillin concentrations used (0 to 100 μg mL−1 oxacillin) (Fig. 5 A
and F). The disappearance of the R phase did not result from au-
tolysis induced by cotreatment of the cells with moenomycin and
oxacillin (SI Appendix, Fig. S8) but was caused by a change in the
sensitivity to CbpD-B6. This demonstrates that without functional
class A PBPs, nascent peptidoglycan is not converted to the CbpD-
B6-resistant form.
As three different class A PBPs are produced by S. pneumo-
niae (PBP1a, PBP1b, and PBP2a) we wondered whether the
Fig. 5. CbpD sensitivity assays (A–E) demonstrating that class A PBPs are essential for converting PBP2x/FtsW-synthesized peptidoglycan into a CbpD-B6
resistant form. Resistance to CbpD-B6 was tested for different pneumococcal mutants after treatment with different concentrations of oxacillin alone or in
combination with moenomycin. Black arrows indicate the addition of antibiotics, while red arrows indicate the addition of CbpD-B6 (5 μg mL−1) 10 min later.
(A) RH425 cultures treated with moenomycin (10 μg mL−1) in combination with the indicated concentrations of oxacillin before being subjected to CbpD-B6.
(B) Cultures of a mutant strain expressing a low-affinity PBP1a (LA-PBP1a, strain KHB332). Individual cultures are treated with one of the indicated con-
centrations of oxacillin for 10 min before being subjected to CbpD-B6. (C) Same setup as in B, except that strain KHB225 (Δpbp2a/Δpbp1b) was used. (D) Same
setup as in B, except that strain KHB224 (Δpbp1a/Δpbp1b) was used. (E) Same setup as in B, except that strain ds789 (Δpbp2b, ΔlytA, mreCΔaa182-272) was used
and CbpD-B6 was added 15 min subsequent to oxacillin. (F) Schematic summary of the sensitivity of different strains to CbpD-B6 based on the results pre-
sented in Figs. 2 A and B and 5 A–E. Three different phases were observed, namely, sensitivity phase 1 (S1), the resistant phase (R), and sensitivity phase 2 (S2).
The oxacillin concentrations that gave rise to the different phases are indicated above the plot. Δ2b* indicates that the genotype of strain ds789 (Δpbp2b,
ΔlytA, mreCΔaa182-272) is more complex than denoted in E and F. All experiments were performed three times or more, with highly similar results.





























































concerted action of all three is needed for the maturation process.
To answer this question the oxacillin titration experiment was per-
formed with a mutant strain expressing a low-affinity PBP1a protein
from S. mitis B6. Using the same concentration range as before (0
to 100 μg mL−1 oxacillin), we only observed the S1 and R phases in
this experiment. The S2 phase had disappeared and was replaced
with an extended R phase (Fig. 5 B and F). This result shows that
the activity of PBP1a alone is sufficient to transform PBP2x/FtsW-
synthesized peptidoglycan into the CbpD-B6-resistant form.
The class A PBPs of S. pneumoniae strain R6 can be deleted one
at a time and are therefore individually nonessential. PBP1a/
PBP1b and PBP2a/PBP1b double mutants can also be constructed,
whereas PBP1a/PBP2a double mutants are nonviable (6, 7). The
fact that pneumococcal cells need either PBP1a or PBP2a to
survive indicates that these PBPs can, at least to a certain extent,
substitute for each other. If the observed conversion of PBP2x/
FtsW-synthesized peptidoglycan into a CbpD-B6-resistant form
represents an important element in the construction of a mature
pneumococcal cell wall, it would be expected that this processing
step can be carried out also by PBP2a. To address this question, we
performed the oxacillin titration experiment with a Δpbp2a/
Δpbp1b strain and a Δpbp1a/Δpbp1b strain. In both cases we ob-
served the typical S1, R, and S2 phases (Fig. 5 C, D, and F),
demonstrating that PBP2a can substitute for PBP1a in the pepti-
doglycan maturation process.
Finally, to determine whether inhibition of class A PBPs has
any effect on pneumococcal morphology, cells were treated
with moenomycin for 2 h before they were fixed and prepared
for transmission electron microscopy (TEM). The amount of
moenomycin used (0.4 μg mL−1, corresponding to 0.5 × MIC) par-
tially inhibits peptidoglycan polymerization by class A PBPs. The
TEM micrographs revealed that moenomycin-treated cells had
considerably thicker septal cross walls than untreated cells (Fig.
6). In addition, their cell walls were much less electron dense
than wild-type ones, strongly indicating that they have little or no
wall teichoic acid (24) or a more open peptidoglycan mesh
structure.
PBP2b and the Elongasome. Having established that class A PBPs
are essential for converting FtsW/PBP2x-synthesized peptido-
glycan into a CbpD-B6 resistant form, we wanted to determine
whether the process also requires an active elongasome. Un-
fortunately, we are not aware of any β-lactam or other drug to
which PBP2b is more sensitive than the other pneumococcal
PBPs. Consequently, we were not able to specifically inhibit the
transpeptidase activity of PBP2b without running the risk of
inhibiting the activity of the other PBPs as well. Instead, we
carried out the oxacillin titration experiment with a Δpbp2b,
ΔlytA, MreCΔaa182-272 mutant strain (strain ds789), which lacks a
functional elongasome (25). PBP2b is essential in a wild-type
background but can be deleted in a strain expressing a truncated
version of the elongasome protein MreC (25). Moreover, since
pneumococci depleted in PBP2b become hypersensitive to LytA
(8), we deleted the lytA gene to avoid autolysis. Deletion of lytA
does not affect the S1–R–S2 pattern observed when wild-type
pneumococci are subjected to increasing concentrations of oxacil-
lin (SI Appendix, Fig. S9). When performing this experiment, we
observed the usual S1–R–S2 pattern (Fig. 5 E and F), but complete
resistance was not reached when CbpD-B6 was added 10 min
subsequent to oxacillin. However, after 15 min close to full re-
sistance was obtained in cultures treated with 0.19 to 0.75 μg mL−1
oxacillin. This experiment shows that class A PBPs are able to
process PBP2x/FtsW-synthesized peptidoglycan in the absence
of a functional elongasome.
Discussion
Recently, it became clear that FtsW/PBP2x and RodA/PBP2b
constitute cognate pairs of interacting proteins that make up the
core peptidoglycan-synthesizing machineries within the pneu-
mococcal divisome and elongasome, respectively (9–11). Both
couples consist of a monofunctional transglycosylase working
together with a monofunctional transpeptidase. This discovery
has important implications for our understanding of pneumo-
coccal cell wall synthesis and the role played by class A PBPs in
this process. Before it was discovered that the SEDS proteins
FtsW and RodA have glycosyltransferase activity, class A PBPs
Fig. 6. TEM micrographs of S. pneumoniae RH425 cells grown without (A) or with moenomycin (0.4 μg mL−1) for 2 h (B–D). The moenomycin-treated cells
display thickened cell walls with low electron density, especially in the division zones. The experiment was performed twice with the same result.





















































were considered to be the only peptidoglycan polymerases pre-
sent in pneumococci. Hence, they were regarded as key com-
ponents of the divisome and elongasome and indispensable for
septal as well as peripheral peptidoglycan synthesis. This way of
thinking is no longer valid, and the function of class A PBPs has
therefore become an open question.
Using CbpD-B6 as a tool, we show that class A PBPs act down-
stream of the FtsW/PBP2x machinery to produce alterations in the
cell wall. Class A PBPs are able to function, i.e., to convert FtsW/
PBP2x-synthesized peptidoglycan into a CbpD-B6-resistant form,
even when PBP2x is completely inhibited by oxacillin. Similarly, we
show that class A PBPs are able to operate independently of PBP2b
and the elongasome in a Δpbp2b, ΔlytA, MreCΔaa182-272 mutant.
Since the conversion process takes about 3.5 min (Fig. 4), the activity
of class A PBPs occurs subsequent to and separate in time from
FtsW/PBP2x-mediated peptidoglycan synthesis. These results are in
agreement with the observation that the FtsW/PBP2x machinery as
well as class A PBPs localize to the division site in S. pneumoniae
(26). They also fit well with data obtained by high-resolution 3D-
SIMmicroscopy showing that the positions of PBP2x and PBP1a are
similar in predivisional stages, while PBP1a lags behind PBP2x
during septal constriction (27). Together our findings provide three
important insights: 1) Class A PBPs have a distinct and unique role
in the construction of the pneumococcal cell wall, 2) there exists a
class A–mediated mechanism that remodels nascent FtsW/PBP2x-
synthesized peptidoglycan into a more mature CbpD-B6-resistant
form, and 3) this maturation mechanism is essential.
It is well established that the divisome and elongasome con-
stitute two separate peptidoglycan-synthesizing machineries (5).
Their activities are precisely coordinated during the cell cycle,
but experiments have shown that the divisome is able to operate
in the absence of the elongasome and vice versa. Pneumococcal
cultures treated with oxacillin (0.1 μg mL−1) at a concentration
that inhibits PBP2x, but not class A PBPs and PBP2b, give rise to
highly elongated cells with no septal cross walls (SI Appendix,
Fig. S10 B and C). This demonstrates that the elongasome is
active even in the absence of a functional divisome. Similar
findings were reported previously by others (5, 27–29). In the
opposite case, several studies showed that pneumococci are able
to grow and form septal cross walls when PBP2b is depleted or
deleted (8, 25, 30, 31). Pneumococci that are strongly depleted in
PBP2b form long chains of round cells that are compressed in
the direction of the long axis (SI Appendix, Fig. S10 D and E). In
the present study, we have obtained evidence that class A PBPs
operate independently of the divisome and elongasome and
hence function autonomously. An important question is there-
fore whether PBP1a, PBP2a, and PBP1b operate alone or in
multiprotein complexes similar to the divisome and elongasome.
It was reported that PBP1a forms a complex with CozE, MreC,
and MreD (32) and that it coimmunoprecipitates with the cell
cycle protein GpsB (33). Interestingly, it was shown that aberrant
PBP1a activity can be detected outside the midcell zone in
pneumococci lacking MreC or CozE, supporting the model that
PBP1a can function autonomously (32). PBP2a, on the other
hand, interacts with and is regulated by MacP, a substrate of the
global cell cycle regulator StkP (34). The interplay between the
two PBPs and their respective partners appears to be specific, as
interactions between CozE/PBP2a and MacP/PBP1a have not
been detected (32, 34). Presumably, the specific partners of
PBP1a and PBP2a are important for the precise spatiotemporal
regulation of their activity. Together the data support a model in
which PBP1a, PBP2a, and PBP1b are the key players in three
separate and autonomous peptidoglycan-synthesizing machiner-
ies with partially overlapping functions.
The fact that class A PBP-mediated remodeling of nascent
peptidoglycan is inhibited by oxacillin as well as moenomycin
strongly indicates that both catalytic domains of these proteins
are actively involved in the remodeling process. Hence, the
remodeling mechanism most likely involves the synthesis of new
glycan strands and the incorporation of these strands into
existing peptidoglycan (Fig. 7). How could peptidoglycan syn-
thesis by class A PBPs make the cell wall resistant to CbpD-B6?
The muralytic enzyme consists of three different domains, a
catalytic CHAP domain, an SH3b domain, and a choline-binding
domain that anchors CbpD-B6 to teichoic acid. The SH3b do-
main probably acts as an auxiliary module that binds peptido-
glycan and facilitates the function of the catalytic CHAP domain
(16). Previous research showed that all three domains are re-
quired for the enzyme to be active (16). Hence, it would be
sufficient to block the function of one of these domains to
convert the cell wall into a CbpD-B6-resistant form. Inhibiting
the activity of the CHAP domain would require that nascent
peptide bridges cross-linked by PBP2x be altered to become
resistant to the enzyme. A structural change in these peptide
Fig. 7. Model illustrating the role of class A PBPs in the synthesis of pneumococcal peptidoglycan. The core peptidoglycan-synthesizing machinery, PBP2x and
FtsW, of the divisome (yellow shading) produces the primary CbpD-sensitive peptidoglycan (shown in shades of gray), which is subsequently remodeled by
class A PBPs into a CbpD-resistant form (shown in shades of green).





























































bridges might also block the binding of the SH3b domain, as the
SH3b domain of lysostaphin was reported to bind to the peptide
part of the cell wall of Staphylococcus aureus (35). The peptide
bridges in pneumococcal peptidoglycan consist of a mixture of
branched and unbranched cross-links. The branches are intro-
duced by the aminoacyl ligases MurM and MurN. MurM cata-
lyzes the addition of L-Ala or L-Ser, whereas the addition of the
second L-Ala is catalyzed by MurN (36). However, as a strain
lacking murMN behaved exactly like the wild type when subjected
to the oxacillin titration assay (SI Appendix, Fig. S11), alterations
in branching are not important for CbpD-B6 resistance. Alterna-
tively, we speculated that the SH3b domain recognizes the glycan
part of pneumococcal peptidoglycan instead of the peptide part.
Thus, the oxacillin titration assay was performed with ΔpgdA and
Δadr mutant strains as well. The pdgA gene encodes a peptido-
glycan N-acetylglucosamine deacetylase, while the adr gene encodes
a peptidoglycan O-acetyl transferase (37, 38). The ΔpgdA and Δadr
strains displayed an S1–R–S2 pattern similar to the wild-type strain,
demonstrating that neither N-acetylation nor O-acetylation signifi-
cantly affects the ability of CbpD-B6 to cleave pneumococcal pep-
tidoglycan during the S1 and S2 phases (SI Appendix, Fig. S12 A and
B). Furthermore, it is possible that class A PBP-mediated remodeling
of pneumococcal peptidoglycan affects the ability of CbpD-B6 to
attach to teichoic acid via its C-terminal choline-binding domain,
resulting in CbpD resistance. However, we could not detect any
significant difference between cells treated with 0.8 μg mL−1 oxacillin
(R phase cells) and untreated cells with respect to sfGFP-CbpD-B6
binding patterns (Fig. 3).
Considering that S. pneumoniae must express either PBP1a or
PBP2a to be viable, class A PBPs must serve an essential func-
tion. PBP1a appears to have the most prominent role among
class A PBPs, as highly β-lactam resistant pneumococci always
express low-affinity versions of PBP1a in addition to PBP2x and
PBP2b. We clearly show that class A PBPs together with their
associated auxiliary proteins somehow remodel the primary
peptidoglycan synthesized by the PBP2x/FtsW machinery. As
discussed above, this remodeling might involve chemical or
structural modifications of the primary peptidoglycan that inhibit
the function of the CHAP, SH3b, or Cbd domain of CbpD-B6.
Alternatively, class A PBPs and their helper proteins might not
synthesize peptidoglycan that is qualitatively different from the
primary peptidoglycan synthesized by PBP2x/FtsW, but rather
might function as a repair machinery that mends imperfections
that arise during construction and expansion of the cell wall (10).
This idea is in accordance with the findings of a recently published
study on E. coli. Vigouroux et al. (39) reported that PBP1b, the
major class A PBP in this species, contributes to maintain cell wall
integrity by actively repairing cell wall defects. It is conceivable
that the peptidoglycan layer synthesized by PBP2x/FtsW, i.e., the
divisome, is not perfect. It might not be fully homogenous but
might contain irregularities in the form of gaps and small holes.
We speculate that CbpD-B6 uses these irregularities to penetrate
into the peptidoglycan layer. Perhaps CbpD-B6 is not able to di-
gest “tightly woven” peptidoglycan but depends on imperfections
to get access to its substrate.
TEM micrographs of pneumococci treated with moenomycin
showed that the electron density of their cross walls was strongly
reduced (Fig. 6). This supports the idea that PBP2x/FtsW-
synthesized peptidoglycan has less wall teichoic acid and/or a
more open architecture. The pore size of peptidoglycan has been
estimated to be around 2 nm (40). This represents a formidable
physical barrier to the assembly of large proteins and cell wall–
spanning complexes that are larger than the pores. In the case of
peptidoglycan-spanning machineries such as flagella and type III
and IV secretion systems, the problem was solved by the re-
cruitment of lytic transglycosylases or other muralytic enzymes
that locally rearrange the cell wall (41). By analogy, it was as-
sumed that muralytic enzymes create gaps in the peptidoglycan
layer to allow the insertion or penetration of large proteins and
pili (42, 43). However, if the peptidoglycan synthesized by
PBP2x/FtsW inherently is more open, i.e., has more gaps and/or
larger pores, it would facilitate the insertion of larger protein
components, and local degradation of peptidoglycan might not
be necessary. This idea fits with the fact that most bacterial
proteins translocated across the cytoplasmic membrane are
exported by the general secretory SecA-YEG pathway which is
localized at midcell septa (44, 45).
We propose a model in which class A PBPs further process the
peptidoglycan meshwork synthesized by PBP2x and FtsW to
remove imperfections and/or make it denser (Fig. 7). A denser
peptidoglycan can be obtained by adding peptidoglycan that is
more heavily cross-linked or by introducing more wall teichoic
acid. Thus, class A PBPs might together constitute a repairosome
that repairs gaps and imperfections in the primary peptidoglycan
synthesized by PBP2x/FtsW and/or function to strengthen the
primary cell wall before it is exposed to turgor pressure and the
external milieu. Since there are three different class A PBPs, it is
possible that they together serve both functions. Further studies
are required to confirm or reject these ideas.
Materials and Methods
All data, strains, oligonucleotides, and experimental procedures used in this
study are provided in the main article and SI Appendix.
Cultivation and Transformation of Bacteria. All strains used in the present
study are listed in SI Appendix, Table S1. Escherichia coli was grown in Luria
Bertani (LB) broth or on LB agar plates at 37 °C containing ampicillin (100 μgmL−1)
when necessary. Liquid cultures were grown aerobically with shaking.
Chemically competent E. coli cells were transformed by heat shocking at
42 °C. S. pneumoniae was grown in liquid C medium (46) or on Todd-Hewitt
(TH) agar plates (BD Difco) at 37 °C. When grown on TH agar the cells were
incubated in a sealed container made anaerobically (<1% O2) by including
AnaeroGen sachets from Oxoid. Transformation of S. pneumoniae was done
by adding CSP-1 (final concentration of 250 ng mL−1) and the transforming
DNA (50 to 100 ng) to 1 mL of exponentially growing cells at OD550 = 0.05.
Following incubation at 37 °C for 2 h, transformants were selected by
plating 30 μL of cell culture on TH agar plates containing the appropriate
antibiotic: kanamycin (400 μg mL−1), streptomycin (200 μg mL−1), or spectino-
mycin (200 μg mL−1).
Depletion of FtsW and PBP2x. During cultivation of strains css12 and SPH163,
ectopic expression of FtsW and PBP2x was maintained by the addition of
0.2 μM of ComS to the growth medium. ComS is a peptide pheromone
consisting of seven amino acids (LPYFAGC). Exogenous peptide pheromone
is internalized by the native Ami oligopeptide permease. In the cytoplasm it
directly interacts with and activates the constitutively expressed ComR
transcriptional activator. In the activated state ComR binds to its cognate
comX promoter, which has been engineered to drive the ectopic expression
of FtsW (strain css12) and PBP2x (strain SPH163). In depleted cells the ComS
peptide is removed from the medium by replacing ComS-containing medium
with ComS-free medium. The ComRS system originates from Streptococcus
thermophilus, where it regulates competence for natural transformation.
See Berg et al. for further details (8, 23).
Immunodetection of FtsW-3xFlag. A C-terminally 3xFlag-tagged version of
FtsW (FtsW-3xFlag) was ectopically expressed using the ComRS system (strain
gs1709). Depletion of FtsW-3xFlag was performed as described above in 5 mL
cultures. Parallel cultures induced with 0.2 μM ComS were used as controls.
When the level of FtsW-3xFlag was reduced to a concentration rendering
the cells immune to CbpD-B6, the cells were harvested at 4,000 × g. Cell
lysates were prepared for sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and immunodetected as previously described (47).
The anti-Flag antibody (F7425, Sigma-Aldrich) used to detect FtsW-3xFlag
was diluted 1:4,000.
DNA Cloning. All primers used in this study are listed in SI Appendix, Table S2.
To construct pRSET-cbpD-B6, the cbpD-B6 gene from S. mitis B6 was amplified
from genomic DNA using the primer pair so1/so2. The gene was amplified
without the signal sequence encoding part, starting from codon 41. The
cbpD-B6 amplicon was cleaved with XbaI and HindIII and ligated into pRSET A





















































(Invitrogen), generating pRSET-cbpD-B6. The plasmid pRSET-sfGFP-cbpD-B6
was constructed by substituting the CHAP encoding part (amino acids 41 to
175) of cbpD-B6 with the sf-gfp gene. The sf-gfp gene was amplified using
the kp116 and kp119 primers and SPH370 genomic DNA as a template, and
the cbpD-B6-Δchap gene was amplified from SO7 genomic DNA using the
primer pair kp117/kp118. Using overlap extension PCR and the primers
kp116 and kp117, sf-gfp was fused to cbpD-B6-Δchap. The resulting sf-gfp-
cbpD-B6 amplicon was cleaved with NdeI and HindIII and ligated into pRSET
A, giving the pRSET-sfGFP-cbpD-B6 plasmid.
Amplicons used to transform S. pneumoniae were constructed by overlap
extension PCR as previously described by Johnsborg et al. (48). We employed
the Janus cassette (49) to knock out genes and to introduce recombinant
DNA at desired positions in the S. pneumoniae genome. When substituting
the native pbp2x gene with a low-affinity version (pbp2x-exB6), an addi-
tional version of the native gene was ectopically expressed during trans-
formation using the ComRS system as described by Berg et al. (23). The
spectinomycin-resistant marker aad9 was employed to knock out lytA in
strain ds789.
Expression and Purification of CbpD-B6. E. coli BL21 containing pRSET-cbpD-
B6 was grown to OD550 = 0.4 to 0.5 at 37 °C. Then production of CbpD-B6
was induced by adding a final concentration of 0.1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) followed by incubation at 20 °C for 4 h. The
cells were harvested at 5,000 × g for 5 min and resuspended in 1/100 culture
volume of Tris-buffered saline (TBS) at pH 7.4. The cells were lysed using the
Fast Prep method with ≤106 μm glass beads at 6.5 m s−1, and insoluble
material was removed by centrifugation at 20,000 × g. CbpD-B6 was purified
from the soluble protein fraction by performing DEAE cellulose chroma-
tography as described by Sanchez-Puelles et al. (20), but using TBS (pH 7.4)
instead of a phosphate buffer (pH 7.0). To remove choline from the eluted
CbpD-B6 protein, it was dialyzed against TBS (pH 7.4) for 1 h at room tem-
perature. After concentrating the dialyzed protein to a final volume of
500 μL using an Amicon centrifugal filter (10,000 MW), it was further purified
by gel filtration through a Superdex 75 10/300 GL column (GE Healthcare) at a
flow rate of 0.3 mL min−1 in TBS (pH 7.4).
CbpD-B6 Resistance Assay. Pneumococcal cells were grown in 96-well micro-
titer plates, and OD550 was measured every 5 min. When reaching OD550 = 0.2,
oxacillin was added in concentrations decreasing from 100 μg mL−1 down to
0.003 μg mL−1 in a twofold dilution series. Cells with zero antibiotic added
were used as controls. In some cases, 10 μg mL−1 of moenomycin were added
together with oxacillin. The cells were grown for 10 min in the presence of
antibiotics before purified CbpD-B6 was added to a final concentration of
5 μg mL−1. CbpD-sensitive cells were observed as a drop in OD550. For the
time kinetic experiments, oxacillin (0.8 μg mL−1) was added simultaneously
with 11 parallel cell cultures grown in a 96-well microtiter plate. Then CbpD-B6
(1 μg mL−1) was added to the first well at time 0, then to the second well after
1 min and so on for 10 min.
Microscopy. For TEM and SEM analyses, strain RH425 was grown to OD550 =
0.2, and CbpD-B6 was added to a final concentration of 0.5 μg mL−1. The
enzyme was allowed to attack the cells for 1 min at 37 °C before they were
fixed in a mixture of 2% (v v−1) formaldehyde and 2.5% volume–volume ratio
(v v−1) glutaraldehyde. The cells were fixed on ice for 1 h and then prepared
for SEM and TEM imaging as previously described by Straume et al. (50).
RH425 cells grown for 2 h (from OD550 = 0.1 to OD550 = 0.4) with 0.4 μg mL−1
moenomycin or 0.1 μg mL−1 oxacillin and SPH157 cells depleted for PBP2b
[as described by Berg et al. (8)] were fixed and prepared for electron mi-
croscopy in the same way.
To determine the binding pattern of CbpD-B6 on sensitive and immune S.
pneumoniae cells, a 10 mL cell culture of S. pneumoniae was split in two
when reaching OD550 = 0.2. One half was left untreated, while oxacillin was
added to the other half to a final concentration of 0.8 μg mL−1. Both cultures
were incubated further for 10 min at 37 °C before formaldehyde was added
to a final concentration of 2.5%. Both nontreated and oxacillin-treated cells
were fixed on ice for 1 h. The fixed cells were washed three times in 1/5
volume of phosphate-buffered saline (PBS), before sfGFP-CbpD-B6 (purified
as described for CbpD-B6) was bound to the cell surface as described by
Eldholm et al. (16). Briefly, 100 μL of cells were applied to a microscope glass
slide (inside a hydrophobic frame made with a PAP pen), and cells were
immobilized by incubation at room temperature for 5 min. Nonbound cells
were rinsed off the glass by PBS. Cells were then incubated in 100 μL PBS
containing 0.05% Tween 20 and 15 μg mL−1 sfGFP-CbpD-B6 for 8 min at
room temperature. Nonbound sfGFP-CbpD-B6 was washed off the cells by
rinsing the glass slide by submerging the glass slide in five tubes each con-
taining 40 mL of PBS. Phase contrast pictures and GFP fluorescence pictures
were captured using a Zeiss AxioObserver with an ORCA‐Flash4.0 V2 Digital
CMOS camera (Hamamatsu Photonics) through a 100× PC objective. An HPX
120 Illuminator was used as a light source for fluorescence microscopy. Phase
contrast pictures of FtsW-depleted cells were captured as described above.
Images were prepared in ImageJ.
Statistical Analysis. To determine the relationship between reduction in OD550
and minutes of oxacillin treatment (Fig. 4), the following sixth-order equa-
tion was used: y = −0.0047x6 + 0.1661x5 − 2.2897x4 + 14.975x3 − 43.815x2 +
28.423x + 66.23. The experiment was repeated three times, and the data are
presented as mean ± SD.
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